title: Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial.
authors: Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy.
authors: G
authors: G
authors: Ceccarelli
authors: Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy ivan.schietroma@uniroma1.it.
authors: I
authors: I
authors: Schietroma
authors: Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy.
authors: G
authors: G
authors: Corano Scheri
authors: Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy.
authors: G
authors: G
authors: d'Ettorre
authors: Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy.
authors: V
authors: V
authors: Vullo
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung; D006801:Humans; D008175:Lung Neoplasms; D009364:Neoplasm Recurrence, Local; D019936:Probiotics; D052999:Quinazolinones
chemical_list: D052999:Quinazolinones; C525726:dacomitinib